Navigation Links
OFS to Present Paper on Optical Fibers with Polyimide Coatings for Medical Applications
Date:1/19/2012

cient, cost-effective transmission.

OFS' corporate lineage dates back to 1876 and includes technology powerhouses such as AT&T and Lucent Technologies (now Alcatel-Lucent. Today, OFS is owned by Furukawa Electric, a multi-billion dollar global leader in optical communications.

Headquartered in Norcross (near Atlanta) Georgia, U.S., OFS is a global provider with facilities in Avon, Connecticut; Carrollton, Georgia; Somerset, New Jersey; and Sturbridge, Massachusetts, as well as in Denmark, Germany and Russia. For more information, please visit www.ofsoptics.com.

About OFS, Specialty Photonics Division

OFS, Specialty Photonics Division, is an industry leader in optical fiber design or modification for highly specialized or customized applications. It supplies advanced optical fibers, including specialty multimode, specialty single-mode, rare-earth doped, polarization-maintaining and other nonstandard fibers. It also manufactures specialty cables and connectors, and other specialty products, such as high-power laser components. For more information about the Specialty Photonics Division, please visit: www.SpecialtyPhotonics.com.


'/>"/>
SOURCE OFS, Specialty Photonics Division
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII ... and commercializing innovative therapies addressing major unmet medical ... in its first Phase 2a study, RXI-109-1301.  The ... 1-month findings that were reported in September of ... http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , , , ...
(Date:12/15/2014)... and Markets ( http://www.researchandmarkets.com/research/bf3b6l/electrocardiogram ) has announced ... Global Trends, Estimates and Forecasts, 2012-2018" report to ... Global Electrocardiogram Devices (ECG) sector is projected ... North America accounts for nearly 36% (2015) ... claims approximately 27% (2018). Asia-Pacific ...
(Date:12/15/2014)... PLYMOUTH MEETING, Pa. , Dec. 15, 2014 ... ) announced today it has been added to ... the NASDAQ Biotechnology Index will become effective upon ... The NASDAQ Biotechnology Index is designed to track ... that are classified as either biotechnology or pharmaceutical ...
Breaking Medicine Technology:RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4
... Amgen Inc. (Nasdaq: AMGN ),today released ... of,the long-term safety and efficacy of Nplate(TM) (romiplostim) ... Chronic ITP is a,chronic and serious autoimmune disorder ... blood, sometimes leading to serious bleeding events.,The results ...
... BEACH, California and AMSTERDAM, December 8 ,Agendia, a ... that,leading Agendia and the Netherlands Cancer Institute researchers ... San Antonio Breast Cancer Symposium,(SABCS) and Agendia will ... Individualized Breast Cancer Therapy symposium. The San Antonio,Breast ...
Cached Medicine Technology:Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients 2Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients 3Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients 4Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients 5Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients 6Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients 7Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients 8Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients 9Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients 10Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients 11Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients 12Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 2Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 3Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 4
(Date:12/19/2014)... December 19, 2014 After a 13-year ... is again returning to the stage to entertain his ... for concert performances, and the successful tour has been ... announced. , Visit Ticketability.com for a ... Detroit shows at fair prices. , Music fans have ...
(Date:12/19/2014)... Consilium Staffing, Your Partner in ... for Federal Health Professionals annual meeting in Washington, ... military and federal healthcare providers. , In ... Business Engagement (NVSBE) conference last week in Atlanta, ... vital solution in addressing our nation’s shortage of ...
(Date:12/19/2014)... in good shape seems to reduce your risk of high ... more than 57,000 Americans, including more than 35,000 with high ... Those in the poorest shape had a more than ... start of the study, compared to a 50 percent chance ... more than 8,000 people diagnosed with high blood pressure during ...
(Date:12/19/2014)... 2014 (HealthDay News) -- The tragic death from "rat-bite fever" ... by the pet rodents, according to a report from the ... is a rare but potentially fatal illness that should be ... when a history of rodent exposure is reported," said a ... Intelligence Service. The case outlined in the report occurred ...
(Date:12/19/2014)... Dotinga HealthDay Reporter ... including ibuprofen, might slightly reduce your risk of developing ... of ibuprofen (Advil, Motrin) and naproxen (Aleve) appear to ... 15 percent, the researchers concluded after reviewing nine prior ... sun exposure. These painkillers "have potential ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Consilium Staffing Increasing Awareness of Locum Tenens through Conference Appearances 2Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Scratch From Pet Rat Kills Child; CDC Warns of Risk 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3
... heart patients make use of all 36 Medicare-funded sessions, researchers ... rehabilitation sessions for elderly people with heart disease can lower ... new research finds, but fewer than one in five eligible ... of more than 30,000 Medicare patients aged 65 and older ...
... , WASHINGTON, Dec. 21 ... for passage of the amended Senate health system reform bill ... Care Act by the Senate will bring our nation close ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) , "All Americans deserve affordable, ...
... , ... tradition of charitable giving at Projects In Knowledge ( www.projectsinknowledge.com ... holiday season. Over the last few months, the company has ... global organizations, all aimed at providing seasonal cheer and assistance ...
... , AVENTURA, Fla., Dec. 21 Cinergy Health ... for the consumer market, expressed its concern for the ongoing healthcare ... , "While the Senate and House healthcare bills are far from ... expanding access to affordable health coverage for all Americans," said ...
... cars shrinks and reaction times grow, study finds , MONDAY, ... themselves and others in danger as they switch their attention ... Researchers who placed young adults in a virtual driving simulator ... car ahead shrank when texting came into the mix, but ...
... to ensure protection, experts say, , MONDAY, Dec. 21 ... flu vaccine may be enough to guard children and ... the U.S. Centers for Disease Control and Prevention recommends ... H1N1 vaccine, spaced about a month apart. This is ...
Cached Medicine News:Health News:With Cardiac Rehab, More Is Better: Study 2Health News:AMA Announces Support for Passage of Senate Health Reform Bill 2Health News:AMA Announces Support for Passage of Senate Health Reform Bill 3Health News:Projects In Knowledge(R) Is Brightening the Holidays for Many in Need 2Health News:Projects In Knowledge(R) Is Brightening the Holidays for Many in Need 3Health News:Projects In Knowledge(R) Is Brightening the Holidays for Many in Need 4Health News:Cinergy Health Commentary on Senate Healthcare Vote 2Health News:Texting While Driving Raises Crash Risk Sixfold 2Health News:Single Shot of H1N1 Vaccine May Be Enough for Kids 2Health News:Single Shot of H1N1 Vaccine May Be Enough for Kids 3
A modular concept consisting of two J-Arms, to be fixed at any position of the skull clamp, allowing to the surgeon an unobstructed access to the surgical field....
Spoon end periosteal, polished finish, designed for large mucoperiosteal flaps....
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
Cushing Little Joker periosteal elevators, solid handle, blade width 1/4" (6 mm), length 7 1/2" (191 mm)....
Medicine Products: